PPLPHARMA - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 4.0

📈 Strong volume and stable technical indicators make PPLPHARMA a favorable intraday candidate today.

📈 Positive

• 📊 MACD at 1.29 and RSI at 52.4 suggest neutral-to-bullish momentum.
• 📈 Price trading near DMA 50 (₹199) and DMA 200 (₹203), indicating short-term support.
• 📊 Volume of 47.1 lakh is significantly above 1-week average of 31.7 lakh, showing strong intraday interest.
• 📈 Quarterly PAT up 32.7%, indicating earnings recovery.
• 📈 DII holding increased by 0.64%, reflecting domestic institutional confidence.

⚠️ Limitation

• 📉 P/E of 37.0 vs. industry P/E of 33.1 suggests slight overvaluation.
• 📉 PEG ratio of 1.67 indicates moderate valuation relative to growth.
• 📉 ROCE at 12.4% and ROE at 9.74% show average capital efficiency.
• 📉 Dividend yield of 0.07% offers minimal income support.

🚫 Company Negative News

• 📉 FII holding dropped by 0.59%, showing foreign investor caution.
• 📉 Price has declined nearly 35% from 52-week high, indicating long-term weakness.

✅ Company Positive News

• 💊 Strong performance in specialty pharma and export segments driving recent earnings growth.
• 📢 Expansion in regulated markets and product launches support future revenue visibility.

🏭 Industry

• 🧪 Industry P/E of 33.1 reflects moderate growth expectations in pharmaceuticals and healthcare.
• 📈 Demand for generics and specialty formulations supports sector fundamentals.

📌 Conclusion

• ✅ PPLPHARMA is a good intraday candidate with strong volume and stable technical indicators.
• 💡 Consider buying near ₹198–₹200 with target at ₹206–₹210 and stop-loss at ₹195.
• 📤 If already holding, exit if price crosses ₹208 with volume > 50 lakh or RSI > 58.

I can also help you chart PPLPHARMA’s intraday support and resistance zones for sharper trade execution.